Recent investigations into retatrutide, a dual stimulant for GLP-1 and GIP receptors, are revealing encouraging effects in addressing weight gain and related non-insulin-dependent diabetes. Initial data suggest a https://shopretatrutidepeptide.com/2026/03/12/what-is-retatrutide-peptide/